Jahanzaib Khwaja

Jun 5, 2024 | onlinelibrary.wiley.com | Joshua Bomsztyk |Sriram Ravichandran |Jahanzaib Khwaja |Oliver Cohen

INTRODUCTION Systemic AL amyloidosis is a condition whereby an abnormal free light chain (FLC), produced by an underlying clonal disorder, misfold and form insoluble amyloid fibrils that deposit in multiple organs resulting in progressive organ dysfunction.1 Anti-plasma cell directed therapies are employed to target the amyloid-producing clonal disorder with a view to reducing or eliminating FLC production.

Jan 3, 2024 | onlinelibrary.wiley.com | Ceri Bygrave |Jahanzaib Khwaja |Joshua Bomsztyk |Maria Atta

CONFLICT OF INTEREST STATEMENT JK, JB, MA, CB, AF, SD, SF, JT, PP, GB, CC, OS, RB, RS, AR and SM: nil to declare. MG: honoraria—Janssen, Amgen and Alnylam; travel support—Novartis, Janssen, Takeda, Stemline therapeutics; consultant—Amgen, Sanofi, Celgene, Stemline therapeutics, Janssen; honoraria—Janssen, Amgen, Alnylam. KJ: Advisory Boards—GSK. AW: honoraria—GSK, Alexion, Attralus, Janssen; travel support—Takeda. REFERENCES 1, , , , , , et al.

Nov 3, 2023 | onlinelibrary.wiley.com | Bylsma LC |Jahanzaib Khwaja |Nicole Japzon |Maria Gabriel

Supporting Information Filename Description bjh19185-sup-0001-Supinfo.docxWord 2007 document , 12.3 KB Data S1. REFERENCES 1, , , , , , et al. Cold agglutinin disease revisited: a multinational, observational study of 232 patients. Blood. 2020; 136(4): 480–488. 2, , , , , , et al. Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial. Blood. 2022; 140(9): 980–991. 3, , , , , , et al.

Nov 3, 2023 | pericles.pericles-prod.literatumonline.com | Bylsma LC |Jahanzaib Khwaja |Nicole Japzon |Maria Gabriel

Filename Description bjh19185-sup-0001-Supinfo.docxWord 2007 document , 12.3 KB Data S1. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

Sep 19, 2023 | onlinelibrary.wiley.com | Jahanzaib Khwaja |Aisha Dadi Patel |Tessa E. Pluimers |Nicole Japzon

CONFLICT OF INTEREST STATEMENT JK, TEP, NJ, AP, SS, AJK, RG, AR and CK have nothing to declare. JMIV has received reimbursement of travel costs from Celgene, receives research funding from BeiGene (institutional) and has participated in an advisory board as well as acted as a consultant for Sanofi (institutional honoraria).